Published in Gene Therapy Weekly, December 16th, 2004
According to recent research from Australia, "ocular neovascularization is the leading cause of blindness in developed countries and the most potent angiogenic factor associated with neovascularization is vascular endothelial growth factor (VEGF). We have previously described a sense oligonucleotide (ODN-1) that possesses anti-human and rat VEGF activity."
"This paper describes the synthesis of lipid-lysine dendrimers and their subsequent ability to delivery ODN-1 to its target and mediate a reduction in VEGF concentration both in vitro and in vivo," said R.J. Marano and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly